Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed vs Sequential Lidocaine and Bupivacaine for SCBPB in AVF Creation
NCT06570096Completed
- Sponsor
- Tanta University
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine and bupivacaine in pain (2 arms), sponsored by Tanta University. Primary endpoint: Percentage of participants with a complete four-nerve sensory block. Started Aug 2024; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06570096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570096.